Events

Patent protection for EU funding beneficiaries - Artificial Intelligence in Medtech
OCT
Tue
22
09:30 - 11:00

This was 1 year ago

Location

Online

Programmes
Health EIC EIT AI Continent

This lecture series, co-organised by the European Patent Office (EPO) and the European IP Helpdesk, addresses the IP-related aspects of EU-funded projects. It introduces the main aspects of IP management: notably IP ownership, protection and exploitation.

This edition explores the interface between patents and artificial intelligence in Med Tech.

On the agenda:

  • Introduction
  • Presentation of main aspects of IP management in EU-funded projects
  • Getting to know patents
  • Patentability of new technological developments in Medtech
  • Learning resources
  • Q&A


More information and registration on the dedicated webpage.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of PREMIERE: ILVO participates in research strengthening the multi-actor approach

PREMIERE: ILVO participates in research strengthening the multi-actor approach

Funded under Horizon Europe (HORIZON-CL6-2022-GOVERNANCE-01-14), running from 2023 to 2027, PREMIERE aims to strengthen the multi-actor approach by supporting the development of more relevant, coherent, and well-prepared project proposals. Flanders Research Institute for Agriculture, Fisheries and Food (EV ILVO) is partner in the project consortium and leads the work package on the development and dissemination of practical tools to help stakeholders prepare successful multi-actor proposals. Read more about the project in this testimonial.